Wire · opportunities
New blood test to detect colon cancer clears FDA approval
◆ Sectors
Health
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 2 September 2026 · Fusion42 review
The FDA approved SimpleScreen, a new blood test by Freenome to detect colorectal cancer in adults 45 and older at average risk, aiming to increase screening rates and enable earlier detection.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You can now offer a simpler, less invasive colorectal cancer screening that removes a key barrier to diagnosis. This opens a new channel for reaching patients who avoid colonoscopies but need early detection.
◆ Coverage
1 source · 3 Aug 2026
◆ Related on Wire
◆ Topics
Healthfda-approvalblood-testcolorectal-cancerearly-detectionhealthtech